Morpholino

MO2-etv6

ID
ZDB-MRPHLNO-150226-1
Name
MO2-etv6
Previous Names
  • UTRmo (1)
Target
Sequence
5' - TCTTGTGTTTCCACTTTCCTCTCCT - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-etv6
Expressed Gene Anatomy Figures
epoa Fig. 2 from Rasighaemi et al., 2015
gata1a Fig. 2,  Fig. 3,  Fig. 5 from Rasighaemi et al., 2015
hbbe1.1 Fig. 2,  Fig. 3,  Fig. 5 from Rasighaemi et al., 2015
ikzf1 Fig. 6 from Rasighaemi et al., 2015
lyz Fig. 4,  Fig. 6 from Rasighaemi et al., 2015
mmp9 Fig. 4,  Fig. 6 from Rasighaemi et al., 2015
myb Fig. 5 from Rasighaemi et al., 2015
rag1 Fig. 6 from Rasighaemi et al., 2015
spi1b Fig. 4 from Rasighaemi et al., 2015
tal1 Fig. 2 from Rasighaemi et al., 2015
Phenotype
Phenotype resulting from MO2-etv6
Phenotype Fish Figures
blood cell hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 Fig. 3 from Rasighaemi et al., 2015
blood cell gata1a expression increased amount, abnormal WT + MO2-etv6 Fig. 3 from Rasighaemi et al., 2015
common lymphoid progenitor rag1 expression increased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
common lymphoid progenitor ikzf1 expression increased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
hematopoietic stem cell hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 Fig. 5 from Rasighaemi et al., 2015
hematopoietic stem cell myb expression decreased amount, abnormal WT + MO2-etv6 Fig. 5 from Rasighaemi et al., 2015
hematopoietic stem cell gata1a expression increased amount, abnormal WT + MO2-etv6 Fig. 5 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 Fig. 2 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm tal1 expression decreased amount, abnormal WT + MO2-etv6 Fig. 2 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal WT + MO2-etv6 Fig. 2 from Rasighaemi et al., 2015
kidney myb expression decreased amount, abnormal WT + MO2-etv6 Fig. 5 from Rasighaemi et al., 2015
macrophage lyz expression decreased amount, abnormal WT + MO2-etv6 Fig. 4 from Rasighaemi et al., 2015
mesoderm mmp9 expression increased amount, abnormal WT + MO2-etv6 Fig. 4 from Rasighaemi et al., 2015
myeloid cell mmp9 expression decreased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
myeloid cell spi1b expression decreased amount, abnormal WT + MO2-etv6 Fig. 4 from Rasighaemi et al., 2015
myeloid cell lyz expression increased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
thymus myb expression decreased amount, abnormal WT + MO2-etv6 Fig. 5 from Rasighaemi et al., 2015
whole organism gata1a expression decreased amount, abnormal WT + MO2-etv6 Fig. 2 from Rasighaemi et al., 2015
whole organism mmp9 expression decreased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
whole organism hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 Fig. 2 from Rasighaemi et al., 2015
whole organism has extra parts of type macrophage, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
whole organism has extra parts of type monocyte, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
whole organism epoa expression increased amount, abnormal WT + MO2-etv6 Fig. 2 from Rasighaemi et al., 2015
whole organism lyz expression increased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
whole organism ikzf1 expression increased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
whole organism rag1 expression increased amount, abnormal WT + MO2-etv6 Fig. 6 from Rasighaemi et al., 2015
Phenotype of all Fish created by or utilizing MO2-etv6
Phenotype Fish Conditions Figures
whole organism has extra parts of type macrophage, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 2 from Rasighaemi et al., 2015
common lymphoid progenitor ikzf1 expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
blood cell hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 3 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm gata1a expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 2 from Rasighaemi et al., 2015
whole organism rag1 expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
intermediate cell mass of mesoderm tal1 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 2 from Rasighaemi et al., 2015
blood cell gata1a expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 3 from Rasighaemi et al., 2015
myeloid cell mmp9 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
whole organism gata1a expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 2 from Rasighaemi et al., 2015
hematopoietic stem cell myb expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 5 from Rasighaemi et al., 2015
macrophage lyz expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 4 from Rasighaemi et al., 2015
thymus myb expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 5 from Rasighaemi et al., 2015
whole organism hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 2 from Rasighaemi et al., 2015
hematopoietic stem cell gata1a expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 5 from Rasighaemi et al., 2015
whole organism ikzf1 expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
kidney myb expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 5 from Rasighaemi et al., 2015
whole organism mmp9 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
common lymphoid progenitor rag1 expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
mesoderm mmp9 expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 4 from Rasighaemi et al., 2015
whole organism lyz expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
myeloid cell lyz expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
whole organism epoa expression increased amount, abnormal WT + MO2-etv6 standard conditions Fig. 2 from Rasighaemi et al., 2015
whole organism has extra parts of type monocyte, abnormal WT + MO2-etv6 standard conditions Fig. 6 from Rasighaemi et al., 2015
myeloid cell spi1b expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 4 from Rasighaemi et al., 2015
hematopoietic stem cell hbbe1.1 expression decreased amount, abnormal WT + MO2-etv6 standard conditions Fig. 5 from Rasighaemi et al., 2015
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.